Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05319457 · ClinicalTrials.gov registry record · NA

Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures

A NA study of Lung Cancer, sponsored by University of North Dakota.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT05319457: Completed NA study of Lung Cancer, sponsored by University of North Dakota.

NCT05319457 is a NA study of Lung Cancer that has completed, run by University of North Dakota. The registered enrollment target is 130 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05319457, a NA study of Lung Cancer, has completed, sponsored by University of North Dakota.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to compare the effectiveness of radon information delivered via the radon app vs. a traditional approach (printed brochure). The prevalence of exceptionally high levels of residential radon in ND, coupled with public's poor understanding of this hazard, is a critical public health problem.

Primary Outcome

The rate at which participants order a free radon test kit

Conditions Studied

Interventions

  • OTHER The radon app
  • OTHER Print brochure

Study Locations (1)

North Dakota

  • University of North Dakota - Grand Forks

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2022-05-05
Est. Completion 2022-09-01
Phase NA
University of North Dakota

4 total trials

What the finished NCT05319457 record still lists

NCT05319457 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which The radon app is the first listed.

NCT05319457 reports a single indexed study location in North Dakota.

Frequently Asked Questions

What is clinical trial NCT05319457 about?

NCT05319457 is a clinical study titled "Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures". The purpose of this research study is to compare the effectiveness of radon information delivered via the radon app vs. a traditional approach (printed brochure). The prevalence of exceptionally high levels of residential radon in ND, coupled with public's poor understanding of this hazard, is a cri...

What is the current status of trial NCT05319457?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2022-05-05. Estimated completion is 2022-09-01.

What conditions does trial NCT05319457 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT05319457?

The interventions under investigation include: The radon app (OTHER), Print brochure (OTHER).

Who is sponsoring clinical trial NCT05319457?

This trial is sponsored by University of North Dakota, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05319457 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05319457's enrollment target sits among peer trials

130 162nd of 409 higher than 247 of 409 other Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05319457, the US trial registry maintained by the National Library of Medicine. NCT05319457 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.